Many neurological disorders exhibit sex differences and sex-specific therapeutic responses. Unfortunately, significant amounts of studies investigating molecular and cellular mechanisms underlying these neurological disorders use primary cell cultures with undetermined sexes; and this may be a source for contradictory results among different studies and impair the validity of study conclusion. Herein, we comprehensively compared sexual dimorphism of gene expression in primary neurons, astrocytes, and microglia derived from neonatal mouse brains. We found that overall sexually dimorphic gene numbers were relatively low in these primary cells, with microglia possessing the most (264 genes), neurons possessing the medium (69 genes), and astrocytes possessing the least (30 genes). KEGG analysis indicated that sexually dimorphic genes in these three cell types were strongly enriched for the immune system and immune-related diseases. Furthermore, we identified that sexually dimorphic genes shared by these primary cells dominantly located on the Y chromosome, including Ddx3y, Eif2s3y, Kdm5d, and Uty. Finally, we demonstrated that overexpression of Eif2s3y increased synaptic transmission specifically in male neurons and caused autism-like behaviors specifically in male mice. Together, our results demonstrate that the sex of primary cells should be considered when these cells are used for studying the molecular mechanism underlying neurological disorders with sex-biased susceptibility, especially those related to immune dysfunction. Moreover, our findings indicate that dysregulation of sexually dimorphic genes on the Y chromosome may also result in autism and possibly other neurological disorders, providing new insights into the genetic driver of sex differences in neurological disorders.
Alcoholic liver disease (ALD) is a serious worldwide
health problem.
Ginsenoside Rc is a major active ingredient isolated from Panax ginseng, whose pharmacological effects counteract
oxidative stress, inflammation, and lipid accumulation. However, it
is still unclear whether ginsenoside Rc might exert beneficial effects
on alcohol-induced liver injury. To this aim, mice primary hepatocytes
(MPHs) were challenged with alcohol to test ginsenoside Rc’s
effects on their intracellular alcohol metabolism. C57BL/6J mice or
SIRT6alb–/– mice were chronically fed a diet
with added alcohol or given a single gavage of alcohol with or without
ginsenoside Rc. Analyses of alcohol metabolism, oxidative stress,
inflammation, lipid metabolism, and RNaseq expression were conducted
to explore potential targets exploited by ginsenoside Rc to protect
against ALD. Our results showed that ginsenoside Rc attenuated alcohol-induced
liver injury by regulating oxidative stress, inflammation, and lipid
accumulation both in vivo and in vitro. Ginsenoside Rc did increase the deacetylase activity of SIRT6,
thereby lowering acetylated NRF2 levels, which elevated NRF2’s
stability, and subsequently exerting an antioxidant effect. In keeping
with this, the hepatic knockout of SIRT6 almost abolished the hepatoprotective
effects of ginsenoside Rc against ALD. Therefore, our results suggest
that ginsenoside Rc attenuated hepatocytes’ damage and oxidative
stress in ALD by up-regulating the SIRT6/NRF2 pathway. Hence, ginsenoside
Rc may be a promising drug to treat or relieve ALD.
Background
Microglia play a pivotal role in neuroinflammation, while obesity triggers hypothalamic microglia activation and inflammation. Sirt6 is an important regulator of energy metabolism in many peripheral tissues and hypothalamic anorexic neurons. However, the exact mechanism for microglia Sirt6 in controlling high-fat diet-induced obesity remain unknown.
Methods
Microglia Sirt6 expression levels under various nutritional conditions were measured in the hypothalamus of mice. Also, microglia Sirt6-deficient mice were provided various diets to monitor metabolic changes and hypothalamic inflammatory response. Besides, RNA-seq and Co-IP of microglia with Sirt6 alterations were conducted to further investigate the detailed mechanism by which Sirt6 modulated microglia activity.
Results
We found that Sirt6 was downregulated in hypothalamic microglia in mice given a high-fat diet (HFD). Additionally, knockout of microglia Sirt6 exacerbated high-fat diet-induced hypothalamic microglial activation and inflammation. As a result, mice were more prone to obesity, exhibiting a decrease in energy expenditure, impaired glucose tolerance, insulin and leptin resistance, and increased food intake. In vitro, Sirt6 overexpression in BV2 cells displayed protective effects against oleic acid and palmitic acid treatment-derived inflammatory response. Mechanically, Sirt6 deacetylated and stabilised NRF2 to increase the expression of anti-oxidative genes and defend against reactive oxygen species overload. Pharmacological inhibition of NRF2 eliminated the beneficial modulating effects of Sirt6 on microglial activity.
Conclusion
Collectively, our results revealed that microglial Sirt6 was a primary contributor of microglial activation in the central regulation of obesity. Thus, microglial Sirt6 may be an important therapeutic target for obesity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.